An Israeli university specializing in medical cannabis
Israel has taken another step forward in the world of cannabis. took another step forward in the cannabis space. In fact, Ariel University offers the very first university course specializing in medical cannabis. The country has been the pioneer of cannabis research since the late 1960, when the Dr Raphael Mechoulam was the first to research the psychoactive properties of the plant (THC). Today, Israel will be the first country to offer formal academic training on medical cannabis.
Israel, in the foreground
Israeli researchers have continued to make vital contributions to cannabis research. Now students will be able to train specifically in medical cannabis. The course is recognized by the Council of Higher Education. Students will learn a wide range of topics, including the legal status and history of medical cannabis. As well as cutting-edge training in cannabis cultivation, the clinical applications of the herb, and the ethical dilemmas that accompany cannabis therapies.
Already, 117 students have been accepted and many more have been refused. This is a good sign for the program's popularity in the future, but also for its quality. The program was launched by Dr. Michael Dor. Dor, a talented man, is the keynote speaker on health issues at the University of Medical Sciences. The doctor is also the senior advisor of the Ministry of Health and a former ministerial official. He will lead the new course at Ariel University.
The priority of registration is for people with experience in the health sector. All students must have a minimum of one year of schooling. Clinical trials will be the main focus of the course. More clinical trials on cannabis products are piling up. However, trials have been limited in the past by strict research regulations in other countries.
The inability to patent the cannabis plant is likely to have also contributed to the lack of pharmaceutical research on the subject. But, the new Dor program is a major step towards better integration of the plant into medical communities. This will encourage a more enlightened medical use, and hopefully, more high quality research in the field.
Unfortunately for those interested in recreational cannabis, the class has a strict focus on medical cannabis. The plant is illegal for recreational and non-medical purposes in Israel. Marijuana is still considered a hard drug, just like cocaine. . During the course, students will receive an opinion from an anti-drug authority on the social harm of the non-medical use of cannabis.
Israel bans the occasional use of cannabis, but its cannabis medical program has been expanding. Thousands of patients are now receiving medical cannabis to relieve the symptoms of cancer, epilepsy and other debilitating health conditions. Israeli producers have also introduced impressive medical strains into the market. One is Avidekel, raised by Tikun-Olam. Avidekel is a cannabis plant with a high content of CBD.
In a pre-clinical study of 2015, Avidekel extracts outperformed isolated CBD in rodent inflammation tests. In 2014, some even speculated that Israel is preparing to become the world leader in the medicinal cultivation of cannabis.